Zacks
0
All posts from Zacks
Zacks in Our Research. Your Success.,

Cambrex (CBM) Catches Eye: Stock Adds 8.5% in Session

Cambrex Corporation CBM was a big mover last session, as the company saw its shares rise almost 9% on the day. The rally came on the back of an encouraging first-quarter 2016 release. This also led to far more shares changing hands than in a normal session. This breaks the recent trend for the company, as the stock is now trading above the volatile price range of $42.55 to $46.84 in the past one-month time frame.

In the past 30 days, the company has not seen any estimate revision and the Zacks Consensus Estimate also remained unchanged. Friday’s price action is encouraging though, so make sure to keep a close watch on this firm in the near future.

Cambrex currently has a Zacks Rank #3 (Hold).

A better-ranked biomedical stock is ANI Pharmaceuticals, Inc. ANIP with a Zacks Rank #1 (Strong Buy).

Is CBM going up? Or down? Predict to see what others think: Up or Down

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
CAMBREX CORP (CBM): Free Stock Analysis Report
 
ANI PHARMACEUT (ANIP): Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research